Dr. Reddy's Laboratories Limited (RDDA) — Cash Flow Quality Index
Dr. Reddy's Laboratories Limited (RDDA) has a Cash Flow Quality Index of 0.90x as of December 2025. Operating cash flow of €10.91 Billion is below net income of €12.10 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore RDDA debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Dr. Reddy's Laboratories Limited Cash Flow Quality Index (2017–2025)
Historical Cash Flow Quality Index for Dr. Reddy's Laboratories Limited across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see Dr. Reddy's Laboratories Limited (RDDA) cash conversion ratio.
Annual Cash Flow Quality Index for Dr. Reddy's Laboratories Limited (2017–2025)
Year-by-year earnings quality comparison for Dr. Reddy's Laboratories Limited.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.82x | €46.43 Billion | €56.54 Billion | ▲ +0.8% |
| 2024 | 0.81x | €45.43 Billion | €55.78 Billion | ▼ -37.7% |
| 2023 | 1.31x | €58.88 Billion | €45.07 Billion | ▲ +9.5% |
| 2022 | 1.19x | €28.11 Billion | €23.57 Billion | ▼ -36.0% |
| 2021 | 1.86x | €35.70 Billion | €19.15 Billion | ▲ +21.8% |
| 2020 | 1.53x | €29.84 Billion | €19.50 Billion | ▲ +0.2% |
| 2019 | 1.53x | €28.70 Billion | €18.80 Billion | ▼ -16.9% |
| 2018 | 1.84x | €18.03 Billion | €9.81 Billion | ▲ +2.9% |
| 2017 | 1.79x | €21.51 Billion | €12.04 Billion | — |